IVERIC bio Inc. (ISEE)
NASDAQ: ISEE
· Real-Time Price · USD
39.95
0.15 (0.38%)
At close: Jul 10, 2023, 10:00 PM
IVERIC bio Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -229.08M | -189.91M | -159.97M | -142.04M | -122.49M | -114.69M | -107.16M | -108.06M | -96.86M |
Interest Income | 5.59M | 2.26M | 876K | 718K | 301K | 245K | 247K | 238K | 219K |
Pretax Income | -222.9M | -185.21M | -159.18M | -141.38M | -122.26M | -114.52M | -106.92M | -107.82M | -96.65M |
Net Income | -220.32M | -184.24M | -158.21M | -140.41M | -122.26M | -114.52M | -106.92M | -107.82M | -96.27M |
Selling & General & Admin | 92.54M | 72.89M | 53.77M | 42.87M | 33.48M | 29.69M | 29.71M | 29.7M | 29.28M |
Research & Development | 136.54M | 117.01M | 106.27M | 99.23M | 89.08M | 85.07M | 77.44M | 78.35M | 67.58M |
Other Expenses | 61K | 62K | -30K | 9K | 1K | n/a | n/a | n/a | n/a |
Operating Expenses | 229.08M | 189.91M | 160.03M | 142.1M | 122.56M | 114.76M | 107.16M | 108.06M | 96.86M |
Interest Expense | 2.13M | 2.26M | 815K | 615K | 133K | n/a | 500K | 500K | 500K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 229.08M | 189.91M | 160.03M | 142.1M | 122.56M | 114.76M | 107.16M | 108.06M | 96.86M |
Income Tax Expense | -10.77M | -9.42M | -1.57M | -1.14M | -108K | 235K | 234K | 236K | -213K |
Shares Outstanding (Basic) | 137.09M | 121.04M | 120.28M | 119.69M | 118.75M | 115.07M | 105.22M | 93.41M | 93.31M |
Shares Outstanding (Diluted) | 137.09M | 121.04M | 120.28M | 119.69M | 118.75M | 115.07M | 105.22M | 93.41M | 93.31M |
EPS (Basic) | -1.74 | -1.51 | -1.33 | -1.21 | -1.13 | -1.13 | -1.11 | -1.15 | -1.15 |
EPS (Diluted) | -1.74 | -1.51 | -1.33 | -1.21 | -1.13 | -1.13 | -1.11 | -1.15 | -1.15 |
EBITDA | -231.35M | -192.23M | -159.91M | -141.94M | -122.35M | -114.48M | -106.86M | -107.74M | -96.53M |
EBIT | -222.38M | -182.95M | -158.37M | -140.8M | -122.22M | -114.69M | -106.59M | -107.49M | -96.3M |
Depreciation & Amortization | -2.24M | -2.29M | 95K | 66K | 47K | 39K | 59K | 84K | 118K |